Literature DB >> 9551938

Gene organization and promoter function for CC chemokine receptor 5 (CCR5).

F Guignard1, C Combadiere, H L Tiffany, P M Murphy.   

Abstract

CC chemokine receptor 5 (CCR5) functions physiologically as a receptor for the leukocyte chemoattractants macrophage inflammatory protein-1alpha, macrophage inflammatory protein-1beta, and RANTES, and functions pathologically as a key cell entry coreceptor for HIV-1. The factors that regulate CCR5 expression may be useful therapeutic targets for HIV-1 infection. To identify nuclear regulatory factors, we have located and functionally characterized the CCR5 gene promoter. The gene consists of two exons separated by a 1.9-kb intron. Exon 1 contains 43 bp of the 5'-untranslated region; exon 2 contains 11 bp of the 5'-untranslated region and the complete open reading frame. Primer extension analysis identified two adjacent transcriptional start points (tsp) that map to the first 2 bp found in the longest known CCR5 cDNA sequence. A TATA box is present 31 bp upstream from the first tsp. CCR5 mRNA was detected constitutively in both primary human myeloid and lymphoid cells by Northern blot hybridization. Consistent with this, transcription of a chloramphenicol acetyltransferase reporter gene was constitutively activated in both transiently transfected myeloid and lymphoid cell lines by the 80-bp gene fragment located immediately upstream of the tsp. Deletion analysis located a strong silencer element between nucleotides -244 and -80, and a strong enhancer element between -486 and -244. These results suggest that the gene region between -486 and -1 may regulate the expression of CCR5 in monocyte/macrophages and T lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9551938

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  16 in total

1.  Characterization of chemokine receptor utilization of viruses in the latent reservoir for human immunodeficiency virus type 1.

Authors:  T Pierson; T L Hoffman; J Blankson; D Finzi; K Chadwick; J B Margolick; C Buck; J D Siliciano; R W Doms; R F Siliciano
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

2.  Codon optimization of bacterial luciferase (lux) for expression in mammalian cells.

Authors:  Stacey S Patterson; Hebe M Dionisi; Rakesh K Gupta; Gary S Sayler
Journal:  J Ind Microbiol Biotechnol       Date:  2005-03-11       Impact factor: 3.346

3.  CCR5Delta32 59537-G/A promoter polymorphism is associated with low translational efficiency and the loss of CCR5Delta32 protective effects.

Authors:  Qingwen Jin; Lokesh Agrawal; L Meyer; R Tubiana; Ioannis Theodorou; Ghalib Alkhatib
Journal:  J Virol       Date:  2007-12-19       Impact factor: 5.103

4.  Transcriptional regulation of the chemokine co-receptor CCR5 by the cAMP/PKA/CREB pathway.

Authors:  Anupam Banerjee; Vanessa Pirrone; Brian Wigdahl; Michael R Nonnemacher
Journal:  Biomed Pharmacother       Date:  2011-05-30       Impact factor: 6.529

5.  Genetic variation at chemokine receptor CCR5 in leporids: alteration at the 2nd extracellular domain by gene conversion with CCR2 in Oryctolagus, but not in Sylvilagus and Lepus species.

Authors:  C R Carmo; P J Esteves; N Ferrand; W van der Loo
Journal:  Immunogenetics       Date:  2006-04-05       Impact factor: 2.846

6.  Cloning and functional characterization of the human fractalkine receptor promoter regions.

Authors:  Alexandre Garin; Philippe Pellet; Philippe Deterre; Patrice Debré; Christophe Combadière
Journal:  Biochem J       Date:  2002-12-15       Impact factor: 3.857

7.  Mycobacterium avium complex augments macrophage HIV-1 production and increases CCR5 expression.

Authors:  S M Wahl; T Greenwell-Wild; G Peng; H Hale-Donze; T M Doherty; D Mizel; J M Orenstein
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-13       Impact factor: 11.205

8.  Kruppel-like factor 2 modulates CCR5 expression and susceptibility to HIV-1 infection.

Authors:  Max W Richardson; Julie Jadlowsky; Chuka A Didigu; Robert W Doms; James L Riley
Journal:  J Immunol       Date:  2012-09-17       Impact factor: 5.422

9.  Epigenetic control of CCR5 transcript levels in immune cells and modulation by small molecules inhibitors.

Authors:  Rutger J Wierda; Hedwich F Kuipers; Marja C J A van Eggermond; Anne Benard; Jan C van Leeuwen; Silvia Carluccio; Sacha B Geutskens; J Wouter Jukema; Victor E Marquez; Paul H A Quax; Peter J van den Elsen
Journal:  J Cell Mol Med       Date:  2012-08       Impact factor: 5.310

10.  CCR2-64I polymorphism is not associated with altered CCR5 expression or coreceptor function.

Authors:  R Mariani; S Wong; L C Mulder; D A Wilkinson; A L Reinhart; G LaRosa; R Nibbs; T R O'Brien; N L Michael; R I Connor; M Macdonald; M Busch; R A Koup; N R Landau
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.